U.S. will again offer free at-home Covid tests starting in late September

U.S. will again offer free at-home Covid tests starting in late September


Images By Tang Ming Tung | DigitalVision | Getty Images

The Biden administration on Friday said it will resume offering free at-home Covid-19 tests to American households in late September as the virus has gained a stronger foothold in the U.S. this summer.

Americans will soon be able to use COVIDtests.gov to request four free tests, administration officials told reporters during a briefing. The tests will be able to detect the Covid variants that are currently circulating, most of which are descendants of the highly contagious omicron variant JN.1. 

“These tests will help keep families and their loved ones safe this fall and winter season,” Dawn O’Connell, an assistant secretary for preparedness and response at the Health and Human Services Department, said during the briefing. “This is the seventh time over the last three years that the Biden-Harris administration has given families the opportunity to order the over-the-counter Covid-19 tests for free” through the government’s website.

The government’s program has provided more than 1.8 billion free over-the-counter Covid tests to Americans since it started in 2021, according to O’Connell.

The government is relaunching the program amid a relatively large spike in Covid cases this summer, and ahead of the fall and winter, when the virus typically spreads at higher levels each year. There is a “high” or “very high” level of Covid being detected in wastewater in almost every U.S. state, according to data from the Centers for Disease Control and Prevention. 

But the government decided to reopen the program in late September because it’s when more Americans begin to travel and gather indoors with loved ones. 

More CNBC health coverage

“As people start to travel, as they start to get together with friends and family through the holidays, we want them to have those four tests available to them at that time,” David Boucher, director of infectious disease preparedness and response at HHS, told reporters during the briefing.

By then, the latest round of Covid shots from Pfizer and Moderna will be available to most Americans in pharmacies, health clinics and other locations nationwide. The Food and Drug Administration approved those shots, which target a JN.1 offshoot called KP.2, on Thursday.

Testing is a critical tool for protection as Covid infections climb again. But lab PCR tests — the traditional method of detecting Covid — have become more expensive and less accessible for some Americans since the U.S. government ended the public health emergency in May last year. 

Still, certain local health clinics and community sites offer at-home tests to the public at no cost. 

Don’t miss these insights from CNBC PRO



Source

Healthy Returns: FDA launches program to streamline creation of new U.S. drug manufacturing sites 
Health

Healthy Returns: FDA launches program to streamline creation of new U.S. drug manufacturing sites 

FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4, 2009.  Jason Reed | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. A new […]

Read More
FDA may pull authorization of Pfizer’s Covid vaccine for children under 5
Health

FDA may pull authorization of Pfizer’s Covid vaccine for children under 5

A nurse prepares doses of the Pfizer vaccine during a COVID-19 vaccination event at Josephine’s Southern Cooking in Chatham, Illinois, Dec. 30, 2021. Brian Cassella | Tribune News Service | Getty Images The Food and Drug Administration is weighing revoking its authorization of Pfizer‘s Covid-19 vaccine for healthy children under the age of 5, the […]

Read More
Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar
Health

Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar

The Eli Lilly logo is shown on one of the company’s offices in San Diego, California, on Sept. 17, 2020. Mike Blake | Reuters Eli Lilly on Thursday hiked its 2025 guidance and posted second-quarter earnings that topped estimates on strong demand for its blockbuster weight loss and diabetes drugs. The company raised its fiscal 2025 […]

Read More